Rapid Infusion Rituximab for Maintenance Therapy : Is It Feasible?
المؤلفون المشاركون
Sokol, Lubomir
Wetzstein, Gene
Ho, Viet
Djulbegovic, Benjamin
Bello, Celeste
Patel, Jolly
Ho, Melissa
المصدر
Leukemia Research and Treatment
العدد
المجلد 2013، العدد 2013 (31 ديسمبر/كانون الأول 2013)، ص ص. 1-4، 4ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2013-10-31
دولة النشر
مصر
عدد الصفحات
4
التخصصات الرئيسية
الملخص EN
Rituximab is an anti-CD-20 monoclonal antibody used in the management of lymphoproliferative disorders.
The use of maintenance rituximab has improved progression free survival and overall survival in follicular lymphomas.
Although rapid rituximab infusions have been studied extensively, there is little data on the use of rapid infusions during maintenance therapy for low grade lymphomas.
The primary objective of this retrospective analysis was to evaluate the incidence of Grade 3 and 4 toxicities with maintenance rapid infusion rituximab according to the Common Terminology Criteria for Adverse Events version 4 (CTC v.
4).
Secondary objectives included evaluating all grade infusion related adverse events and correlation of adverse events with varying schedules of rituximab maintenance therapy.
All patients who received rapid infusion rituximab as maintenance therapy for low grade lymphoma between December 2007 and November 2011 were included.
Rapid rituximab infusions were administered over 90 minutes.
Demographic, laboratory and clinical data were collected.
A total of 109 patients received 647 rapid rituximab infusions.
Three patients experienced an adverse reaction which resulted in one grade 1 infusion reaction and three grade 3 infusion reactions.
No patients required hospitalization.
All 3 patients received pharmacological and/or supportive care to relieve symptoms associated with the reaction.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Patel, Jolly& Ho, Melissa& Ho, Viet& Bello, Celeste& Djulbegovic, Benjamin& Sokol, Lubomir…[et al.]. 2013. Rapid Infusion Rituximab for Maintenance Therapy : Is It Feasible?. Leukemia Research and Treatment،Vol. 2013, no. 2013, pp.1-4.
https://search.emarefa.net/detail/BIM-486466
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Patel, Jolly…[et al.]. Rapid Infusion Rituximab for Maintenance Therapy : Is It Feasible?. Leukemia Research and Treatment No. 2013 (2013), pp.1-4.
https://search.emarefa.net/detail/BIM-486466
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Patel, Jolly& Ho, Melissa& Ho, Viet& Bello, Celeste& Djulbegovic, Benjamin& Sokol, Lubomir…[et al.]. Rapid Infusion Rituximab for Maintenance Therapy : Is It Feasible?. Leukemia Research and Treatment. 2013. Vol. 2013, no. 2013, pp.1-4.
https://search.emarefa.net/detail/BIM-486466
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-486466
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر